Medical Cannabis regulation slowly advances in Brazil

Medical Cannabis regulation slowly advances in Brazil

Anvisa and Brazilian House of Representatives yield to social pressure and move towards to the universalization of cannabis for medical purposes As scientific evidence advances on the therapeutic benefits of medicinal products made from Cannabis sp. extracts, the number of countries with specific regulations also increases.  Substances from cannabis are being used as an alternative […]

Keep Calm and Be a (Black) Swan – Standalone injunctive relief

Keep Calm and Be a (Black) Swan – Standalone injunctive relief

The British Virgin Islands (BVI) sets itself apart from other offshore and onshore centres through the speed, efficiency and flexibility with which it deals with matters, especially those arising from fraud. Absent a statutory gateway for standalone injunctive relief, the Courts in the BVI have long grappled with extending relief to an aggrieved party who […]

Do Chambers and the Legal 500 have a diversity problem?

Do Chambers and the Legal 500 have a diversity problem?

It’s law firm directory season once again. Marketing professionals everywhere are celebrating the rankings of their firms and individual partners in the latest editions of the Chambers and Legal 500 directories. Their excited, self-congratulatory posts on LinkedIn serve to show just how much they matter. These directories have been part of the legal landscape for […]

Cannabis sativa may attract billions in investments to Brazil

Anvisa is expected to enact rules for the use of Cannabis for medical purposes as early as 2019 Eyes and attention are focused on the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – Anvisa), the Brazilian regulatory agency responsible for the execution of sanitary control, regulation, approval and supervision of pharmaceutical, health […]

What’s your poison? Britain’s drug laws go to pot

What’s your poison? Britain’s drug laws go to pot

Two recent media stories have featured prominently in relation to where Britain’s drug laws are heading. In isolation, the arguments supporting each of them make sense, but put together they demonstrate how contradictory our legal system and public health policy might become, should they both be realised simultaneously. The first story concerned a government green […]